-
公开(公告)号:US20240400707A1
公开(公告)日:2024-12-05
申请号:US18809215
申请日:2024-08-19
Applicant: Avidity Biosciences, Inc.
Inventor: Barbora MALECOVA , Rob BURKE , Beatrice Diana DARIMONT , David SALA CANO
IPC: C07K16/28 , A61K39/00 , A61P21/00 , C12N15/113
Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating facioscapulohumeral muscular dystrophy (FSHD).
-
公开(公告)号:US12157774B2
公开(公告)日:2024-12-03
申请号:US18402604
申请日:2024-01-02
Applicant: Avidity Biosciences, Inc.
Inventor: Barbora Malecova , Rob Burke , Beatrice Diana Darimont , David Sala Cano
IPC: C07K16/28 , A61P21/00 , C12N15/113 , A61K39/00
Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating facioscapulohumeral muscular dystrophy (FSHD).
-
公开(公告)号:US20240287522A1
公开(公告)日:2024-08-29
申请号:US18637337
申请日:2024-04-16
Applicant: Avidity Biosciences, Inc.
Inventor: Barbora MALECOVA , Rob BURKE , David SALA CANO , Beatrice Diana DARIMONT
IPC: C12N15/113 , A61K31/7125 , A61K47/68 , A61K48/00 , A61P21/00 , A61P21/06 , C07K16/28 , C07K19/00
CPC classification number: C12N15/113 , A61K31/7125 , A61K47/6807 , A61K47/6849 , A61K47/6889 , A61K48/005 , A61P21/00 , A61P21/06 , C07K16/2881 , C07K19/00 , C07K2317/55 , C12N2310/11 , C12N2310/14 , C12N2310/31 , C12N2310/313 , C12N2310/321 , C12N2310/3231 , C12N2310/3513 , C12N2320/32
Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating Facioscapulohumeral muscular dystrophy.
-
公开(公告)号:US20240228646A9
公开(公告)日:2024-07-11
申请号:US18489583
申请日:2023-10-18
Applicant: Avidity Biosciences, Inc.
Inventor: Beatrice Diana DARIMONT , Venkata Ramana DOPPALAPUDI , Rachel JOHNS
CPC classification number: C07K16/2881 , A61K47/6811 , A61K47/6849 , A61K2039/505
Abstract: Disclosed herein, in certain embodiments, are anti-transferrin receptor antibodies, anti-transferrin receptor antibody conjugates, and pharmaceutical compositions which comprise the anti-transferrin receptor antibodies or conjugates. In some embodiments, also disclosed herein are methods of delivering a payload utilizing an anti-transferrin receptor antibody described herein, and methods of treatment with use of an anti-transferrin receptor antibody described herein.
-
公开(公告)号:US20240132611A1
公开(公告)日:2024-04-25
申请号:US18489583
申请日:2023-10-17
Applicant: Avidity Biosciences, Inc.
Inventor: Beatrice Diana DARIMONT , Venkata Ramana DOPPALAPUDI , Rachel JOHNS
CPC classification number: C07K16/2881 , A61K47/6811 , A61K47/6849 , A61K2039/505
Abstract: Disclosed herein, in certain embodiments, are anti-transferrin receptor antibodies, anti-transferrin receptor antibody conjugates, and pharmaceutical compositions which comprise the anti-transferrin receptor antibodies or conjugates. In some embodiments, also disclosed herein are methods of delivering a payload utilizing an anti-transferrin receptor antibody described herein, and methods of treatment with use of an anti-transferrin receptor antibody described herein.
-
公开(公告)号:US11912779B2
公开(公告)日:2024-02-27
申请号:US17932653
申请日:2022-09-15
Applicant: Avidity Biosciences, Inc.
Inventor: Barbora Malecova , Rob Burke , Beatrice Diana Darimont , David Sala Cano
IPC: C07K16/28 , A61P21/00 , C12N15/113 , A61K39/00
CPC classification number: C07K16/2881 , A61P21/00 , C12N15/113 , A61K2039/505 , C12N2310/141 , C12N2310/315 , C12N2310/321
Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating facioscapulohumeral muscular dystrophy (FSHD).
-
公开(公告)号:US11834510B2
公开(公告)日:2023-12-05
申请号:US17243362
申请日:2021-04-28
Applicant: Avidity Biosciences, Inc.
Inventor: Beatrice Diana Darimont , Venkata Ramana Doppalapudi , Rachel Johns
IPC: A61K39/395 , C07K16/28 , A61K47/68 , A61K39/00
CPC classification number: C07K16/2881 , A61K47/6811 , A61K47/6849 , A61K2039/505 , C07K2317/24 , C07K2317/51 , C07K2317/52 , C07K2317/56 , C07K2317/565
Abstract: Disclosed herein, in certain embodiments, are anti-transferrin receptor antibodies, anti-transferrin receptor antibody conjugates, and pharmaceutical compositions which comprise the anti-transferrin receptor antibodies or conjugates. In some embodiments, also disclosed herein are methods of delivering a payload utilizing an anti-transferrin receptor antibody described herein, and methods of treatment with use of an anti-transferrin receptor antibody described herein.
-
公开(公告)号:US20220324984A1
公开(公告)日:2022-10-13
申请号:US17308888
申请日:2021-05-05
Applicant: Avidity Biosciences, Inc.
Inventor: Andrew John GEALL , Venkata Ramana DOPPALAPUDI , David Sai-Ho CHU , Michael Caramian COCHRAN , Rachel Elizabeth JOHNS , Palani BALU , Rob BURKE , Beatrice Diana DARIMONT
IPC: C07K16/28 , A61K31/713 , A61P35/02 , A61K47/68 , C12N15/113 , C07K16/30 , A61K31/7088 , A61K48/00 , A61P35/00 , C12N15/88 , A61K47/60
Abstract: Disclosed herein are compositions and pharmaceutical formulations that comprise a binding moiety conjugated to a polynucleic acid molecule and a polymer. Also described herein include methods for treating a cancer which utilize a composition or a pharmaceutical formulation comprising a binding moiety conjugated to a polynucleic acid molecule and a polymer.
-
公开(公告)号:US20220096647A1
公开(公告)日:2022-03-31
申请号:US17499800
申请日:2021-10-12
Applicant: Avidity Biosciences, Inc.
Inventor: Andrew John GEALL , Venkata Ramana DOPPALAPUDI , David Sai-Ho CHU , Michael Caramian COCHRAN , Michael HOOD , Beatrice Diana DARIMONT , Rob BURKE , Yunyu SHI , Gulin Erdogan MARELIUS , Barbora MALECOVA
IPC: A61K47/68 , A61K31/712 , A61K31/713 , C07K16/18 , C12N15/113 , A61P21/00 , A61K39/395
Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle atrophy or myotonic dystrophy.
-
公开(公告)号:US20220033434A1
公开(公告)日:2022-02-03
申请号:US17507669
申请日:2021-10-21
Applicant: Avidity Biosciences, Inc.
Inventor: Beatrice Diana DARIMONT
IPC: C07H21/02 , A61K31/712 , A61K31/7125 , A61K47/50 , C12N15/113 , C12N15/87
Abstract: Disclosed herein are molecules and pharmaceutical compositions that mediate RNA interference against androgen receptor. Also described herein include methods for treating a disease or disorder that comprises a molecule or a pharmaceutical composition that mediate RNA interference against androgen receptor.
-
-
-
-
-
-
-
-
-